Increased risk of polycystic ovary syndrome (PCOS) associated with CC genotype of miR-146a gene variation

References

• Dumitrescu R, Mehedintu C, Briceag I, et al. The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms. J Med Life 2015;8:142.
   PubMedGoogle Scholar
• McCartney CR, Marshall JC. Clinical practice. Polycystic ovary syndrome. N Engl J Med 2016;375:54–64.
   PubMed Web of Science ®Google Scholar
• Goodman NF, Cobin RH, Futterweit W, et al. American association of clinical endocrinologists, american college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - PART 2. Endocrine Practice 2015;21:1415–26.
   PubMed Web of Science ®Google Scholar
• Merkin SS, Phy JL, Sites CK, et al. Environmental determinants of polycystic ovary syndrome. Fertil Steril 2016;106:16–24.
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219–31.
   PubMed Web of Science ®Google Scholar
• Huang M, Xiao J, Zhao X, et al. Four polymorphisms of the CAPN 10 gene and their relationship to polycystic ovary syndrome susceptibility: a meta‐analysis. Clin Endocrinol 2012;76:431–8.
   PubMed Web of Science ®Google Scholar
• Shafi G, Hasan TN, Syed NA, et al. Breast cancer microRNAs: clinical biomarkers for the diagnosis and treatment strategies. 2014;171–82.
   Google Scholar
• Lan W, Wang J, Li M, et al. Predicting microRNA-disease associations based on improved microRNA and disease similarities. IEEE/ACM Transact Comput Biol Bioinform 2016;1:99.
   Google Scholar
• Sorensen AE, Udesen PB, Wissing ML, et al. MicroRNAs related to androgen metabolism and polycystic ovary syndrome. Chem Biol Interact 2016;259(Pt A):8–16.
   Web of Science ®Google Scholar
• Long W, Zhao C, Ji C, et al. Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers. Cell Physiol Biochem 2014;33:1304–1315.
   PubMed Web of Science ®Google Scholar
• Piehl F, Jagodic M. MicroRNAs as promising novel biomarkers and potential drug targets for inflammatory neurological diseases. J Neurol Sci 2015;356:3–4.
   PubMed Web of Science ®Google Scholar
• Reddy KB. MicroRNA (miRNA) in cancer. Cancer Cell Int 2015;15:38
   PubMed Web of Science ®Google Scholar
• Pescador N, Pérez-Barba M, Ibarra JM. Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. PLoS One 2013;8:e77251.
   PubMed Web of Science ®Google Scholar
• Mishra PJ, Humeniuk R. MicroRNA polymorphisms. 2013.
   Google Scholar
• Nelson PT, Wang WX, Rajeev BW. MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol 2008;18:130–138.
   PubMed Web of Science ®Google Scholar
• Cho SH, Chung KW, Kim JO, et al. Association of miR-146aC > G, miR-149C > T, miR-196a2T > C, and miR-499A > G polymorphisms with risk of recurrent implantation failure in Korean women. Eur J Obstet Gynecol Reprod Biol 2016;202:14–19.
   PubMed Web of Science ®Google Scholar
• Kim YR, Hong SH. Associations of microRNA polymorphisms (miR-146a, miR-196a2, and miR-499) with the risk of hypertension in the Korean population. Genet Test Mol Biomarkers 2016;20:420–6.
   PubMed Web of Science ®Google Scholar
• Sung JH, Kim SH, Yang WI, et al. miRNA polymorphisms (miR146a, miR149, miR196a2 and miR499) are associated with the risk of coronary artery disease. Mol Med Rep 2016;14:2328–42.
   PubMed Web of Science ®Google Scholar
• Imbar T, Eisenberg I. Regulatory role of microRNAs in ovarian function. Fertility and Sterility 2014;101:1524–1530.
   PubMed Web of Science ®Google Scholar
• Lujan ME, Chizen DR, Pierson RA. Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J Obstet Gynaecol 2008;30:671–679.
   Google Scholar
• Baley J, Li J. MicroRNAs and ovarian function. J Ovarian Res 2012;5:8.
   PubMed Web of Science ®Google Scholar
• Maalouf S, Liu W, Pate J. MicroRNA in ovarian function. Cell Tissue Res 2016;363:7–18.
   PubMed Web of Science ®Google Scholar
• Li Y, Fang Y, Liu Y, Yang X. MicroRNAs in ovarian function and disorders. J Ovarian Res 2015;8:51.
   PubMed Web of Science ®Google Scholar
• Sathyapalan T, David R, Gooderham NJ, Atkin SL. Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis. Sci Rep 2015;5. 16890 p.
   PubMed Web of Science ®Google Scholar
• Salimi-Asl M, Mozdarani H, Kadivar M. Up-regulation of miR-21 and 146a expression and increased DNA damage frequency in a mouse model of polycystic ovary syndrome (PCOS). BioImpacts: BI 2016;6:85.
   PubMed Web of Science ®Google Scholar
• Murri M, Insenser M, Fernández-Durán E, et al. Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression. J Clin Endocrinol Metab 2013;98:E1835–E1844.
   PubMed Web of Science ®Google Scholar
• Rusca N, Monticelli S. MiR-146a in immunity and disease. Mol Biol Int 2011;2011. doi:10.4061/2011/437301.
   PubMedGoogle Scholar
• Sang Q, Yao Z, Wang H, et al. Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo. J Clin Endocrinol Metab 2013;98:3068–3079.
   PubMed Web of Science ®Google Scholar
• Sirotkin AV, Ovcharenko D, Grossmann R, et al. Identification of MicroRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen. J Cell Physiol 2009;219:415–420.
   PubMed Web of Science ®Google Scholar
• Ramkaran P, Khan S, Phulukdaree A, et al. miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell Biochem Biophys 2014;68:259.
   PubMed Web of Science ®Google Scholar
• Ciccacci C, Morganti R, Di Fusco D, et al. Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes. Acta Diabetol 2014;51:663.
   PubMed Web of Science ®Google Scholar
• Huang PH. Asymptotics of AIC, BIC, and RMSEA for model selection in structural equation modeling. Psychometrika 2017;82:407–426.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang Y, Li X, et al. Association study of polymorphisms in miRNAs with T2DM in Chinese population. Int J Med Sci 2015;12:875–80.
   PubMed Web of Science ®Google Scholar
• Ludwig M, Finas DF, Al-Hasani S, et al. Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Human Reprod 1999;14:354–358.
   PubMed Web of Science ®Google Scholar
• Marquard KL, Stephens SM, Jungheim ES, et al. Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2011;95:2146–2149.e1.
   PubMed Web of Science ®Google Scholar
• Trounson A, Gosden R, Eichenlaub-Ritter U. Biology and pathology of the oocyte: role in fertility, medicine and nuclear reprograming. 2013: New York: Cambridge University Press.
   Google Scholar
• Fedorcsák P, Dale PO, Storeng R, et al. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Human Reprod 2001;16:1086–1091.
   PubMed Web of Science ®Google Scholar
• Robker RL. Evidence that obesity alters the quality of oocytes and embryos. Pathophysiology 2008;15:115–121.
   PubMedGoogle Scholar
• Katsikis I, Karkanaki A, Misichronis G, et al. Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2011;156:181–185.
   PubMed Web of Science ®Google Scholar
• Toprak S, Yönem A, Çakır B, et al. Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res Paediatr 2001;55:65–70.
   Google Scholar
• Johnstone EB, Davis G, Zane LT, et al. Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population. Gynecol Endocrinol 2012;28: 819–822.
   PubMed Web of Science ®Google Scholar
• Fakhoury H, Tamim H, Ferwana M, et al. Age and BMI adjusted comparison of reproductive hormones in PCOS. J Fam Med Primary Care 2012;1:132.
   PubMedGoogle Scholar
• Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Human Mol Genet 2007;16:1124–1131.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Cullen BR. Sequence requirements for micro RNA processing and function in human cells. RNA 2003;9:112–123.
   PubMed Web of Science ®Google Scholar
• Shen J, Ambrosone CB, DiCioccio RA, et al. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 2008; 29:1963–1966.
   PubMed Web of Science ®Google Scholar